Methotrexate hydrate
SIGMA/06563 - ≥99.0% (sum of enantiomers, HPLC)
Synonym: 4-
CAS Number: 133073-73-1
Empirical Formula (Hill Notation): C20H22N8O5 · xH2O
Molecular Weight: 454.44 (anhydrous basis)
EC Number: 200-413-8
MDL Number: MFCD00150847
Linear Formula: C20H22N8O5 · xH2O
Product Type: Chemical
| assay | ≥99.0% (sum of enantiomers, HPLC) |
| biological source | synthetic |
| form | powder or crystals |
| impurities | ≤0.1% sulfated ash |
| InChI | 1S/C20H22N8O5.H2O/c1-28(9 |
| InChI key | FPJYMUQSRFJSEW-ZOWNYOTGSA |
| mp | 185-204 °C |
| optical activity | [α]/D +21.0±2.0° |
| Quality Level | 200 ![]() |
| SMILES string | [H]O[H].CN(Cc1cnc2nc(N)nc |
| solubility | water: insoluble |
| storage temp. | −20°C |
| Application: | Methotrexatehydrate has been used as a disease modifyinganti-rheumatic drug (DMARD) to study its effects on Ross River virus disease (RRVD) in mice models. |
| Application: | Potent inhibitor of dihydrofolate reductase and agent for antitumor studies. Use to inhibit dihydrofolate reductase in DHFR-based protein expression systems. |
| Application: | Potent inhibitor of dihydrofolate reductase and agent for antitumor studies. Use to inhibit dihydrofolate reductase in DHFR-based protein expression systems. Also effective in treatment of pyrimethamine-resistant Plasmodium vivax malaria parasites. |
| Application: | Potent inhibitor of dihydrofolate reductase and agent for antitumor studies. Use to inhibit dihydrofolate reductase in DHFR-based protein expression systems. Also shows immunosuppressive effects in, e.g., rheumatoid arthritis. |
| General description: | Methotrexateis an analog of folate. It shows anti-inflammatory effects throughseveral cellular mechanisms. The inhibition of dihydrofolate reductase reducesthe de novo synthesis of pyrimidines and purines, transmetylation ofphospholipids and proteins, and formation of polyamines. |
| Other Notes: | Folic acid antagonist. Potent inhibitor of dihydrofolate reductase. |
| Symbol | ![]() GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H301 - H315 - H319 - H341 - H360D |
| Precautionary statements | P201 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | T |
| Risk Statements | 46-61-25-36/38 |
| Safety Statements | 53-26-36-45 |
| RIDADR | UN 1544PSN1 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Purity | ≥99.0% (sum of enantiomers, HPLC) |
| mp | 185-204 °C |
| Storage Temp. | −20°C |
| UNSPSC | 12352202 |



